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FAMILY PLANNING

EVIDENCE

BRIEF

Expanding contraceptive
choice
“Expanding options and choices for the
poorest women and adolescent girls
is the most important thing we do. By
empowering them to make their own
decisions about the timing and spacing
of pregnancies, we open an important
pathway towards their economic security
and independence, as well as the realization
of all the Sustainable Development Goals.”
—Dr. Natalia Kanem, Executive Director of the United
Nations Population Fund
Approximately 214 million women of reproductive age in developing
regions who want to avoid pregnancy are not using a modern
contraceptive method and are considered to have an unmet need
(1). Expanding contraceptive options for voluntary family planning is
critical to addressing this need for several reasons. First, needs may
vary throughout the reproductive life-course, and individuals have
different desires depending on their personal and family context; 25% of
women want to space their pregnancies, reflecting a need for shorterterm or reversible methods, compared with 14% of women who wish
to cease childbearing and thus limit future pregnancies (2). Second,
some women discontinue contraceptive use even though they want to
avoid pregnancy (3, 4). Reasons for discontinuation include side effects,
myths, contraceptive failure, or the service environment, including
service quality and availability of a sufficient choice of methods (4).

Use of modern contraception increases when more methods
become available: analysis of evidence from 1982–2009

POLICY AND PROGRAMME
CONSIDERATIONS
Establish and maintain wellfunctioning supply chains for an
expanded choice of contraceptives:
Introduce new contraceptive
technologies to satisfy the
diverse preferences of women
and their partners.
Overcome access barriers
to existing methods such as
adverse economic and social
circumstances, including gender
norms.
Maximize the potential of
expanded contraceptive choice
by ensuring a robust supply
chain and improving provider
training and counselling.

CURRENT METHODS OF CONTRACEPTION
Having a wide choice of contraceptives will meet the needs
of some discontinuers if they have the option of switching;
broadened method availability can reduce contraceptive
discontinuation by 8% (5). Third, three-fifths of women
(62%) with unmet need have never used contraception (5),
and a wider range of options may be appealing enough
to some women to try contraception. The addition of one
new method to the available method mix can increase
contraceptive prevalence by as much as eight percentage
points (6). Finally, expanding method choice can ensure
that methods are available for those wanting to protect
against both pregnancy and sexually transmitted infections
including HIV.

CONSIDERATIONS FOR EXPANDING
CONTRACEPTIVE CHOICE
STRATEGIES TO EXPAND
CONTRACEPTIVE OPTIONS
Proven strategies to expand contraceptive options
include introducing new contraceptives to family planning
programmes, expanding access to existing methods, and
expanding the provider base.

Introduce new contraceptive technologies
New contraceptive technologies have been developed
to satisfy the diverse preferences of women and their
partners and to overcome the challenges of providing some
methods in low-resource settings. For example, studies
have shown that DMPA subQ in Uniject (Sayana® Press)
can be provided by grassroots health cadres and by users
themselves, thus reducing reliance on healthcare systems
(7, 8). Studies also suggest that women find Sayana® Press
to be a feasible and acceptable choice of contraception
which is currently being introduced, scaled- up, or piloted
in more than 15 FP2020 countries (9, 10, 11, 12). Other new
product categories include vaginal rings that women can
insert themselves, and can be offered through various
supply outlets ranging from drug stores to tertiary-level
facilities (13, 14). The levonorgestrel (LNG) intrauterine
system and emerging technologies such as a biodegradable
implant, longer-lasting injectables, microCHIPS remotecontrolled contraceptives, and multipurpose prevention
technologies (MPTs) for contraception and HIV and/or STI
prevention hold the promise of an even wider choice of
methods. In addition to vasectomy and tubal ligation, more
affordable, safer, and simpler permanent contraceptive
options for women and men should also be considered,
given that there is substantial unmet need for limiting.

Expand access to existing methods
Overcoming barriers to existing methods such as policy,
geography, and adverse economic and social circumstances
including restrictive gender norms will expand access
to existing methods. For example, expanding access
to implants through mobile outreach programmes and
reducing the price through a volume guarantee resulted
in significant increases in use (15, 16). Similarly, sociocultural barriers to providing services to adolescents can
be overcome in many ways including via comprehensive
sexuality education, gender-transformative programming,
adolescent-friendly services, and providing contraceptives
through a variety of service outlets (17).
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Expand provider base

Method

Task-shifting or task-sharing is the redistribution of
contraceptive counselling and service provision among
different health worker cadres. For example, enabling
community health workers (CHWs) to provide injectables,
like Sayana® Press, and implants has expanded access to
and increased voluntary use of both methods in many
countries (18, 19, 20). Expanding provision to drugstore
and pharmacy staff has also increased access to oral
contraceptive pills, including those for emergency
contraception, and injectables, especially for underserved
populations (21). Increasing the variety of providers allows
users to choose convenient and accessible service delivery
points. Finally, user-initiated contraceptives like fertility
awareness methods and pills are increasingly empowering
women’s independent use of contraceptives, further
expanding access.

Female

Male condom

and individual knowledge and attitudes and promoting
partner communication (28). Satisfied contraceptive users
who speak to others about their experience are also highly
effective in generating demand and changing social norms
related to voluntary family planning (28).
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AND BEYOND
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Expanding the range of contraceptive options helps
individuals to make choices appropriate to their needs and
circumstances, allows them to switch from one method
to another if desired, and reflects a programme focus on
quality and rights.
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acceptability of Sayana® Press: Results from community
health workers and clinic based providers in Uganda and
Senegal,” Contraception, 89(5): 368–373.
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Generate demand
Even with a well-informed provider base, an expanded
method mix can only reach its full potential with continued
demand from users. For example, despite vasectomy’s
well-recognized benefits including high effectiveness,
convenience, permanence, relative ease of provision,
few side effects, and high levels of satisfaction, use of
the method is plagued by low demand among men (27).
Family planning program experience suggests that demand
generation through media campaigns and mobile services
can increase contraceptive use and intention to use modern
contraceptives by improving community

Yes

Permanent contraception

Ensure a robust supply chain

Providers should be trained in client-oriented service
provision for a range of methods in both clinical and
community settings (23, 24). Comprehensive and accurate
counselling allows clients to learn more about contraceptive
options, including managing side effects, benefits, and
possibility of switching (25). Users can then choose a
contraceptive that best suits their need, or switch methods
if they so desire. Addressing lack of provider knowledge
of underutilized methods, like no-scalpel vasectomy, could
also increase contraceptive access (26).

Male

Provider dependent

Long-acting reversible contraceptives (LARCs)

The following actions are essential to ensuring that these
strategies are successful and lead to greater contraceptive
access, uptake, and continuation:

Improve provider training and counselling

Hormonal

Short-acting contraceptives

MAXIMIZING THE POTENTIAL
OF EXPANDING CONTRACEPTIVE
OPTIONS

Ensuring availability of contraceptive supplies at points
of care that are close to clients is essential. Robust
supply chains that eliminate stock- outs and engage
multiple manufacturers to ensure high-quality, lowcost contraceptive products are critical for uptake and
continuation (22).

Gender
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